Mark Leid

Our broad goal is to develop effective, molecularly targeted therapies for improving survival rates and longterm quality of life in children with EwS. Toward that goal, we conducted a high throughput screen of a complex chemical library to identify new drugs to treat this disease. This effort resulted in identification ML111, which potently inhibits EwS cell viability in vitro, as well as that of subsets of hematopoietic and non-small cell lung cancers.

TECHNOLOGIES
CTIP2 Diagnostic Marker for Head and Neck Cancer
Anticancer Compounds
SECTORS
Earth Ecosystems
Health and Wellness
Innovation and Prosperity
CATEGORIES
Agricultural
Biological Materials
Chemical
Chemistry
Communications
Computer
Database
Device
Diagnostics
Digital
Education & Training
Electronics
Engineering
FakeName
Imaging
Information Technology
Materials Science
Medical
Medical Devices
Nanoscience & Microtechnologies
Physical Science
Research Tools
Software
Sustainability & Cleantechnologies
Therapeutics
Transportation
Vaccines
© 2019. All Rights Reserved. Powered by Inteum